{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:58:53Z","timestamp":1792814333486,"version":"4.5.0"},"reference-count":159,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.addr.2008.11.003","type":"journal-article","created":{"date-parts":[[2008,12,17]],"date-time":"2008-12-17T08:06:19Z","timestamp":1229501179000},"page":"3-13","source":"Crossref","is-referenced-by-count":422,"title":["ABCG2: A perspective"],"prefix":"10.1016","volume":"61","author":[{"given":"Robert W.","family":"Robey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K.K.","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orsolya","family":"Polgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Dohse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Fetsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2008.11.003_bb0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.addr.2008.11.003_bb0010","first-page":"1174","article-title":"Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies","volume":"30","author":"Biedler","year":"1970","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF01534700","article-title":"Isolation and genetic characterization of human KB cell lines resistant to multiple drugs","volume":"11","author":"Akiyama","year":"1985","journal-title":"Somat. Cell Mol. Genet."},{"key":"10.1016\/j.addr.2008.11.003_bb0020","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1126\/science.6137059","article-title":"Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines","volume":"221","author":"Kartner","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.addr.2008.11.003_bb0025","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2008.11.003_bb0030","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1073\/pnas.83.12.4538","article-title":"Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells","volume":"83","author":"Roninson","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2008.11.003_bb0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00003088-200140030-00002","article-title":"The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein","volume":"40","author":"Zhang","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.addr.2008.11.003_bb0040","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1158\/1078-0432.CCR-06-2854","article-title":"The blood\u2013brain barrier and cancer: transporters, treatment, and Trojan horses","volume":"13","author":"Deeken","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0045","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.taap.2004.10.012","article-title":"Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense","volume":"204","author":"Leslie","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.addr.2008.11.003_bb0050","first-page":"3657","article-title":"Isolation and characterization of an anthracycline-resistant human leukemic cell line","volume":"45","author":"Bhalla","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0055","first-page":"4955","article-title":"Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy","volume":"51","author":"Gervasoni","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0060","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/bjc.1989.9","article-title":"Effect of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoprotein","volume":"59","author":"Cole","year":"1989","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.addr.2008.11.003_bb0065","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1360704","article-title":"Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line","volume":"258","author":"Cole","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.addr.2008.11.003_bb0070","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00424-006-0160-8","article-title":"Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1\/ABCC1)","volume":"453","author":"Bakos","year":"2007","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.addr.2008.11.003_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0300-483X(01)00454-1","article-title":"Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters","volume":"167","author":"Leslie","year":"2001","journal-title":"Toxicology"},{"key":"10.1016\/j.addr.2008.11.003_bb0080","first-page":"6100","article-title":"Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257","volume":"50","author":"Dietel","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0085","first-page":"6175","article-title":"Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 human breast cancer cells","volume":"52","author":"Nakagawa","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0090","first-page":"4004","article-title":"Cross-resistance to camptothecin analogues in a mitoxantrone-resistant human breast carcinoma cell line is not due to DNA topoisomerase I alterations","volume":"55","author":"Yang","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0095","doi-asserted-by":"crossref","first-page":"10073","DOI":"10.1016\/S0021-9258(19)38781-2","article-title":"Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein","volume":"265","author":"Chen","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2008.11.003_bb0100","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/(SICI)1097-4644(19970615)65:4<513::AID-JCB7>3.0.CO;2-R","article-title":"Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression","volume":"65","author":"Lee","year":"1997","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.addr.2008.11.003_bb0105","article-title":"Cloning and characterization of breast cancer resistance protein (BCRP), a novel ATP-binding cassette (ABC) transporter that may contribute to the multidrug-resistance phenotype of MCF-7\/AdrVp breast cancer cells","volume":"39","author":"Doyle","year":"1998","journal-title":"Proc. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0110","first-page":"5337","article-title":"A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance","volume":"58","author":"Allikmets","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0115","first-page":"8","article-title":"Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes","volume":"59","author":"Miyake","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0120","first-page":"5850","article-title":"Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C","volume":"58","author":"Rabindran","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev.cb.08.110192.000435","article-title":"ABC transporters: from microorganisms to man","volume":"8","author":"Higgins","year":"1992","journal-title":"Annu. Rev. Cell Biol."},{"key":"10.1016\/j.addr.2008.11.003_bb0130","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1101\/gr.GR-1649R","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"11","author":"Dean","year":"2001","journal-title":"Genome Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev.biochem.73.011303.073626","article-title":"ATP-binding cassette transporters in bacteria","volume":"73","author":"Davidson","year":"2004","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.addr.2008.11.003_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygeno.2006.03.001","article-title":"Evolution of the vertebrate ABC gene family: analysis of gene birth and death","volume":"88","author":"Annilo","year":"2006","journal-title":"Genomics"},{"key":"10.1016\/j.addr.2008.11.003_bb0145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.genom.6.080604.162122","article-title":"Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates","volume":"6","author":"Dean","year":"2005","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.addr.2008.11.003_bb0150","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s003350010237","article-title":"An ATP-binding cassette gene (ABCG3) closely related to the multidrug transporter ABCG2 (MXR\/ABCP) has an unusual ATP-binding domain","volume":"12","author":"Mickley","year":"2001","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.addr.2008.11.003_bb0155","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0167-4781(01)00270-6","article-title":"Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene","volume":"1520","author":"Bailey-Dell","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2008.11.003_bb0160","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/(SICI)1098-2264(200001)27:1<110::AID-GCC14>3.0.CO;2-4","article-title":"Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines","volume":"27","author":"Knutsen","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.addr.2008.11.003_bb0165","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cancergencyto.2004.12.013","article-title":"Characterization of ABCG2 gene amplification manifesting as extrachromosomal DNA in mitoxantrone-selected SF295 human glioblastoma cells","volume":"160","author":"Rao","year":"2005","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.addr.2008.11.003_bb0170","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1158\/0008-5472.CAN-03-3583","article-title":"Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene","volume":"64","author":"Ee","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0175","doi-asserted-by":"crossref","first-page":"24218","DOI":"10.1074\/jbc.M313599200","article-title":"The stem cell marker Bcrp\/ABCG2 enhances hypoxic cell survival through interactions with heme","volume":"279","author":"Krishnamurthy","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2008.11.003_bb0180","doi-asserted-by":"crossref","first-page":"23812","DOI":"10.1074\/jbc.M604890200","article-title":"Peroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cells","volume":"281","author":"Szatmari","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2008.11.003_bb0185","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1124\/mol.107.041087","article-title":"Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells","volume":"73","author":"Wang","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.addr.2008.11.003_bb0190","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/carcin\/bgi139","article-title":"Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists","volume":"26","author":"Ebert","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.addr.2008.11.003_bb0195","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1158\/0008-5472.596.65.2","article-title":"Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein\/ABCG2","volume":"65","author":"Imai","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0200","doi-asserted-by":"crossref","first-page":"E798","DOI":"10.1152\/ajpendo.00397.2005","article-title":"Regulation of BCRP\/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells","volume":"290","author":"Wang","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.addr.2008.11.003_bb0205","first-page":"133","article-title":"Effects of sex hormones on regulation of ABCG2 expression in the placental cell line BeWo","volume":"9","author":"Yasuda","year":"2006","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.addr.2008.11.003_bb0210","doi-asserted-by":"crossref","first-page":"8572","DOI":"10.1128\/MCB.00650-06","article-title":"Aberrant promoter methylation of the ABCG2 gene in renal carcinoma","volume":"26","author":"To","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.addr.2008.11.003_bb0215","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1182\/blood-2005-10-009084","article-title":"ABCG2 expression, function and promoter methylation in human multiple myeloma","volume":"108","author":"Turner","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.addr.2008.11.003_bb0220","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1158\/0008-5472.CAN-05-4572","article-title":"Novel 5\u2032 untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usage","volume":"66","author":"Nakanishi","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0225","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1158\/1541-7786.MCR-07-0175","article-title":"Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells","volume":"6","author":"To","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0230","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1128\/MCB.00331-08","article-title":"Regulation of ABCG2 expression at the 3\u2032 untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line","volume":"28","author":"To","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.addr.2008.11.003_bb0235","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1158\/0008-5472.CAN-07-2545","article-title":"ABCG2 expression and side population abundance regulated by a transforming growth factor beta-directed epithelial\u2013mesenchymal transition","volume":"68","author":"Yin","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0240","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1124\/dmd.106.011478","article-title":"Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors","volume":"35","author":"Evseenko","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2008.11.003_bb0245","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/bbrc.2001.5130","article-title":"Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells","volume":"285","author":"Ozvegy","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2008.11.003_bb0250","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1242\/jcs.01729","article-title":"Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2","volume":"118","author":"Henriksen","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.addr.2008.11.003_bb0255","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/ijc.10100","article-title":"Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S\u2013S dependent homodimerization","volume":"97","author":"Kage","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.addr.2008.11.003_bb0260","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1172\/JCI0216000","article-title":"Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface","volume":"110","author":"Graf","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2008.11.003_bb0265","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1021\/bi0479858","article-title":"N-linked glycosylation of the human ABC transporter ABCG2 on asparagine 596 is not essential for expression, transport activity, or trafficking to the plasma membrane","volume":"44","author":"Diop","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2008.11.003_bb0270","doi-asserted-by":"crossref","first-page":"36926","DOI":"10.1074\/jbc.M502937200","article-title":"Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2","volume":"280","author":"Henriksen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2008.11.003_bb0275","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1006\/jmbi.1999.3489","article-title":"The GxxxG motif: a framework for transmembrane helix\u2013helix association","volume":"296","author":"Russ","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.addr.2008.11.003_bb0280","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1021\/bi0497953","article-title":"Mutational analysis of ABCG2: role of the GXXXG motif","volume":"43","author":"Polgar","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2008.11.003_bb0285","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1021\/bi0521590","article-title":"Mutational studies of G553 in TM5 of ABCG2: a residue potentially involved in dimerization","volume":"45","author":"Polgar","year":"2006","journal-title":"Bichemistry"},{"key":"10.1016\/j.addr.2008.11.003_bb0290","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1158\/0008-5472.CAN-06-3169","article-title":"Oligomerization domain of the multidrug resistance-associated transporter ABCG2 and its dominant inhibitory activity","volume":"67","author":"Xu","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0295","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.str.2006.08.014","article-title":"Purification and 3D structural analysis of oligomeric human multidrug transporter ABCG2","volume":"14","author":"McDevitt","year":"2006","journal-title":"Structure"},{"key":"10.1016\/j.addr.2008.11.003_bb0300","doi-asserted-by":"crossref","first-page":"39068","DOI":"10.1074\/jbc.M306362200","article-title":"Akt signaling regulates side population cell phenotype via Bcrp1 translocation","volume":"278","author":"Mogi","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2008.11.003_bb0305","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1124\/dmd.104.003228","article-title":"Regulation of the cell surface expression of human BCRP\/ABCG2 by the phosphorylation state of Akt in polarized cells","volume":"33","author":"Takada","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2008.11.003_bb0310","article-title":"Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues","author":"Fetsch","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.addr.2008.11.003_bb0315","first-page":"3458","article-title":"Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues","volume":"61","author":"Maliepaard","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0320","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/path.1203","article-title":"Frequent expression of the multi-drug resistance-associated protein BCRP\/MXR\/ABCP\/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material","volume":"198","author":"Diestra","year":"2002","journal-title":"J. Pathol."},{"key":"10.1016\/j.addr.2008.11.003_bb0325","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/jnci\/92.20.1651","article-title":"Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan","volume":"92","author":"Jonker","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.addr.2008.11.003_bb0330","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1124\/dmd.107.018044","article-title":"Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse","volume":"35","author":"Zhang","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2008.11.003_bb0335","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.placenta.2008.05.001","article-title":"The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta","volume":"29","author":"Pollex","year":"2008","journal-title":"Placenta"},{"key":"10.1016\/j.addr.2008.11.003_bb0340","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1124\/mol.107.041616","article-title":"The breast cancer resistance protein (Bcrp1\/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study","volume":"73","author":"Zhou","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.addr.2008.11.003_bb0345","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.placenta.2005.11.012","article-title":"Transport of glyburide by placental ABC transporters: implications in fetal drug exposure","volume":"27","author":"Gedeon","year":"2006","journal-title":"Placenta"},{"key":"10.1016\/j.addr.2008.11.003_bb0350","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.placenta.2007.08.004","article-title":"Breast cancer resistance protein: mediating the trans-placental transfer of glyburide across the human placenta","volume":"29","author":"Gedeon","year":"2008","journal-title":"Placenta"},{"key":"10.1016\/j.addr.2008.11.003_bb0355","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/jpet.106.105023","article-title":"Expression and transport activity of breast cancer resistance protein (Bcrp\/Abcg2) in dually perfused rat placenta and HRP-1 cell line","volume":"319","author":"Staud","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2008.11.003_bb0360","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.taap.2008.07.006","article-title":"ABCG2\/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in perfused term human placenta","volume":"232","author":"Myllynen","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.addr.2008.11.003_bb0365","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/00001756-200211150-00014","article-title":"Localisation of breast cancer resistance protein in microvessel endothelium of human brain","volume":"13","author":"Cooray","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.addr.2008.11.003_bb0370","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1471-4159.2004.02537.x","article-title":"Functional expression of rat ABCG2 on the luminal side of brain capillaries and its enhancement by astrocyte-derived soluble factor(s)","volume":"90","author":"Hori","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.addr.2008.11.003_bb0375","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0006-8993(03)02401-6","article-title":"Characterisation of the brain multidrug resistance protein (BMDP\/ABCG2\/BCRP) expressed at the blood\u2013brain barrier","volume":"971","author":"Eisenblatter","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0380","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1096\/fj.02-1131fje","article-title":"The expression and functional characterization of ABCG2 in brain endothelial cells and vessels","volume":"17","author":"Zhang","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2008.11.003_bb0385","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1158\/0008-5472.CAN-03-2033","article-title":"Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood\u2013brain barrier","volume":"64","author":"Cisternino","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0390","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1158\/0008-5472.CAN-04-2416","volume":"65","author":"Breedveld","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0395","article-title":"The effect of P-gp (Mdr1a\/1b), BCRP (Bcrp1) and P-gp\/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib","author":"Oostendorp","year":"2008","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.addr.2008.11.003_bb0400","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/j.1471-4159.2007.04808.x","article-title":"Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood\u2013brain barrier","volume":"102","author":"Bihorel","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.addr.2008.11.003_bb0405","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1007\/s11095-007-9278-4","article-title":"Modulation of the brain distribution of imatinib and its metabolites in mice by valspodar, zosuquidar and elacridar","volume":"24","author":"Bihorel","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0410","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.1158\/1078-0432.CCR-07-1335","article-title":"P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan","volume":"13","author":"de Vries","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0415","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","article-title":"Disruption of mouse mdr-1a p-glycoprotein gene leads to a deficiency in the blood\u2013brain barrier and to increased sensitivity to drugs","volume":"77","author":"Schinkel","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.addr.2008.11.003_bb0420","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1124\/mol.107.034751","article-title":"Effect of breast cancer resistance protein (Bcrp\/Abcg2) on the disposition of phytoestrogens","volume":"72","author":"Enokizono","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.addr.2008.11.003_bb0425","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nm1186","article-title":"The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk","volume":"11","author":"Jonker","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2008.11.003_bb0430","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/carcin\/bgi176","article-title":"Breast cancer resistance protein (Bcrp1\/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk","volume":"27","author":"van Herwaarden","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.addr.2008.11.003_bb0435","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1124\/mol.104.010439","article-title":"The breast cancer resistance protein (BCRP\/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin","volume":"67","author":"Merino","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.addr.2008.11.003_bb0440","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.105.008219","article-title":"Breast Cancer Resistance Protein (BCRP\/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics and milk secretion","author":"Merino","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2008.11.003_bb0445","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2885.2006.00744.x","article-title":"Interaction of enrofloxacin with breast cancer resistance protein (BCRP\/ABCG2): influence of flavonoids and role in milk secretion in sheep","volume":"29","author":"Pulido","year":"2006","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2008.11.003_bb0450","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1128\/MCB.01621-06","article-title":"Multidrug transporter ABCG2\/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk","volume":"27","author":"van Herwaarden","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.addr.2008.11.003_bb0455","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2156-8-32","article-title":"Genetic support for a quantitative trait nucleotide in the ABCG2 gene affecting milk composition of dairy cattle","volume":"8","author":"Olsen","year":"2007","journal-title":"BMC Genet."},{"key":"10.1016\/j.addr.2008.11.003_bb0460","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.3168\/jds.S0022-0302(06)72542-5","article-title":"Short communication: a polymorphism in ABCG2 in Bos indicus and Bos taurus cattle breeds","volume":"89","author":"Ron","year":"2006","journal-title":"J. Dairy Sci."},{"key":"10.1016\/j.addr.2008.11.003_bb0465","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.ejca.2004.05.010","article-title":"The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood\u2013testis barrier and in primary testicular tumours","volume":"40","author":"Bart","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.addr.2008.11.003_bb0470","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1124\/dmd.107.019257","article-title":"Quantitative investigation of the role of breast cancer resistance protein (Bcrp\/Abcg2) in limiting brain and testis penetration of xenobiotic compounds","volume":"36","author":"Enokizono","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2008.11.003_bb0475","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.bcp.2005.05.031","article-title":"Distribution of breast cancer resistance protein (BCRP\/ABCG2) mRNA expression along the human GI tract","volume":"70","author":"Gutmann","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2008.11.003_bb0480","first-page":"417","article-title":"Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C","volume":"1","author":"Allen","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.addr.2008.11.003_bb0485","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1158\/1535-7163.MCT-07-2250","article-title":"Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-\/-\/Mdr1a\/1b-\/- (triple-knockout) and wild-type mice","volume":"7","author":"Marchetti","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.addr.2008.11.003_bb0490","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1124\/mol.104.009753","article-title":"Breast cancer resistance protein (Bcrp1\/Abcg2) limits net intestinal uptake of quercetin in rats by facilitating apical efflux of glucuronides","volume":"67","author":"Sesink","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.addr.2008.11.003_bb0495","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s11095-005-2487-9","article-title":"Lack of improvement of oral absorption of ME3277 by prodrug formation is ascribed to the intestinal efflux mediated by breast cancer resistant protein (BCRP\/ABCG2)","volume":"22","author":"Kondo","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0500","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1158\/1535-7163.MCT-06-0339","article-title":"Role of the ABCG2 drug transporter in the resistance and oral bioavailability of a potent cyclin-dependent kinase\/Aurora kinase inhibitor","volume":"5","author":"Seamon","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.addr.2008.11.003_bb0505","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/mp050113v","article-title":"Breast cancer resistance protein (Bcrp\/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse","volume":"3","author":"Zaher","year":"2006","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2008.11.003_bb0510","first-page":"6447","article-title":"The breast cancer resistance protein (Bcrp1\/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine","volume":"63","author":"van Herwaarden","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0515","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/sj.ki.5002645","article-title":"The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane","volume":"73","author":"Huls","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.addr.2008.11.003_bb0520","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0090-9556(24)02969-6","article-title":"Impaired renal excretion of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) sulfate in breast cancer resistance protein (BCRP1\/ABCG2) knockout mice","volume":"32","author":"Mizuno","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2008.11.003_bb0525","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1124\/dmd.107.016352","article-title":"Evaluation of the role of breast cancer resistance protein (BCRP\/ABCG2) and multidrug resistance-associated protein 4 (MRP4\/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one)","volume":"35","author":"Mizuno","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2008.11.003_bb0530","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1369\/jhc.5A6912.2006","article-title":"Breast cancer resistance protein (BCRP\/ABCG2) is expressed by progenitor cells\/reactive ductules and hepatocytes and its expression pattern is influenced by disease etiology and species type: possible functional consequences","volume":"54","author":"Vander Borght","year":"2006","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.addr.2008.11.003_bb0535","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/labinvest.3700127","article-title":"Subcellular localization of the ABCG2 transporter in normal and malignant human gallbladder epithelium","volume":"84","author":"Aust","year":"2004","journal-title":"Lab. Invest."},{"key":"10.1016\/j.addr.2008.11.003_bb0540","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1124\/mol.105.014019","article-title":"Involvement of BCRP (ABCG2) in the biliary excretion of pitavastatin","volume":"68","author":"Hirano","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.addr.2008.11.003_bb0545","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1124\/dmd.107.014969","article-title":"Involvement of breast cancer resistance protein (ABCG2) in the biliary excretion mechanism of fluoroquinolones","volume":"35","author":"Ando","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2008.11.003_bb0550","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/jpet.106.101840","article-title":"Differential involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in biliary excretion of 4-methylumbelliferyl glucuronide and sulfate in the rat","volume":"319","author":"Zamek-Gliszczynski","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2008.11.003_bb0555","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1124\/mol.106.026955","article-title":"The important role of Bcrp (Abcg2) in the biliary excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in mice","volume":"70","author":"Zamek-Gliszczynski","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.addr.2008.11.003_bb0560","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1124\/dmd.106.012567","article-title":"Involvement of breast cancer resistance protein (BCRP\/ABCG2) in the biliary excretion and intestinal efflux of troglitazone sulfate, the major metabolite of troglitazone with a cholestatic effect","volume":"35","author":"Enokizono","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2008.11.003_bb0565","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.183.4.1797","article-title":"Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo","volume":"183","author":"Goodell","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2008.11.003_bb0570","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm0901-1028","article-title":"The ABC transporter Bcrp1\/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype","volume":"7","author":"Zhou","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2008.11.003_bb0575","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1182\/blood.V99.2.507","article-title":"The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors","volume":"99","author":"Scharenberg","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.addr.2008.11.003_bb0580","doi-asserted-by":"crossref","first-page":"15649","DOI":"10.1073\/pnas.202607599","article-title":"The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria","volume":"99","author":"Jonker","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2008.11.003_bb0585","doi-asserted-by":"crossref","first-page":"12339","DOI":"10.1073\/pnas.192276999","article-title":"Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo","volume":"99","author":"Zhou","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2008.11.003_bb0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425255.4.1.1","article-title":"ABCG2: structure, function and role in drug response.","volume":"4","author":"Polgar","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.addr.2008.11.003_bb0595","first-page":"6635","article-title":"Acquired mutations in the MXR\/BCRP\/ABCP gene alter substrate specificity in MXR\/BCRP\/ABCP-overexpressing cells","volume":"61","author":"Honjo","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0600","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.bjc.6601370","article-title":"Mutations at amino acid 482 in the ABCG2 gene affect substrate and antagonist specificity","volume":"89","author":"Robey","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.addr.2008.11.003_bb0605","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1110\/ps.051998406","article-title":"The nature of amino acid 482 of human ABCG2 affects substrate transport and ATP hydrolysis but not substrate binding","volume":"15","author":"Ejendal","year":"2006","journal-title":"Protein Sci."},{"key":"10.1016\/j.addr.2008.11.003_bb0610","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/ijc.11484","article-title":"Single amino acid substitutions in the transmembrane domains of breast cancer resistance protein (BCRP) alter cross resistance patterns in transfectants","volume":"107","author":"Miwa","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.addr.2008.11.003_bb0615","first-page":"47","article-title":"Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein","volume":"60","author":"Rabindran","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0620","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1158\/1078-0432.CCR-04-1725","article-title":"Cyclosporin A is a broad-spectrum multidrug resistance modulator","volume":"11","author":"Qadir","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0625","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-3835(99)00182-2","article-title":"Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR","volume":"146","author":"de Bruin","year":"1999","journal-title":"Cancer Lett."},{"key":"10.1016\/j.addr.2008.11.003_bb0630","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1158\/0008-5472.CAN-03-3298","article-title":"Pheophorbide a is a specific probe for ABCG2 function and inhibition","volume":"64","author":"Robey","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0635","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1158\/1078-0432.CCR-0914-3","article-title":"VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein","volume":"10","author":"Minderman","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0640","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1349-7006.2003.tb01482.x","article-title":"Reversal of the resistance to STI571 in human chronic myelogenous leukemia K562 cells","volume":"94","author":"Mukai","year":"2003","journal-title":"Cancer Sci."},{"key":"10.1016\/j.addr.2008.11.003_bb0645","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1158\/0008-5472.CAN-03-3344","article-title":"Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro","volume":"64","author":"Houghton","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0650","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1158\/1078-0432.CCR-06-1599","article-title":"The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2","volume":"13","author":"Liu","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0655","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1124\/mol.65.6.1485","article-title":"High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter","volume":"65","author":"Ozvegy-Laczka","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.addr.2008.11.003_bb0660","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1182\/blood.V101.6.2368","article-title":"MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models","volume":"101","author":"Mahon","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.addr.2008.11.003_bb0665","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1182\/blood-2003-01-0083","article-title":"Overexpression of P-glycoprotein in K562 cells does not confer resistance to the growth inhibitory effects of imatinib (STI571) in vitro","volume":"102","author":"Ferrao","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.addr.2008.11.003_bb0670","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2006-02-003145","article-title":"Functional ABCG2 is over-expressed on primary CML CD34+ cells and is inhibited by imatinib mesylate","author":"Jordanides","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.addr.2008.11.003_bb0675","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/sj.leu.2404638","article-title":"Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells","volume":"21","author":"Brendel","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.addr.2008.11.003_bb0680","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.leu.2404897","article-title":"Evidence for the interaction of imatinib at the transport-substrate site(s) of the multidrug-resistance-linked ABC drug transporters ABCB1 (P-glycoprotein) and ABCG2","volume":"22","author":"Shukla","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.addr.2008.11.003_bb0685","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2133\/dmpk.22.428","article-title":"In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs","volume":"22","author":"Tamura","year":"2007","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.addr.2008.11.003_bb0690","first-page":"611","article-title":"C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance","volume":"1","author":"Imai","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.addr.2008.11.003_bb0695","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ijc.11669","article-title":"Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2","volume":"109","author":"Mizuarai","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.addr.2008.11.003_bb0700","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00280-004-0931-x","article-title":"Single nucleotide polymorphisms modify the transporter activity of ABCG2","volume":"56","author":"Morisaki","year":"2005","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.addr.2008.11.003_bb0705","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1124\/mol.106.023556","article-title":"Functional validation of the genetic polymorphisms of human ATP-binding cassette (ABC) transporter ABCG2: identification of alleles that are defective in porphyrin transport","volume":"70","author":"Tamura","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.addr.2008.11.003_bb0710","doi-asserted-by":"crossref","first-page":"650","DOI":"10.4161\/cbt.4.6.1731","article-title":"Effect of ABCG2 genotype on the oral bioavailability of topotecan","volume":"4","author":"Sparreboom","year":"2005","journal-title":"Cancer. Biol. Ther."},{"key":"10.1016\/j.addr.2008.11.003_bb0715","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clpt.2004.03.003","article-title":"Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype","volume":"76","author":"Sparreboom","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2008.11.003_bb0720","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10637-006-6335-5","article-title":"Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypes","volume":"24","author":"Zamboni","year":"2006","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.addr.2008.11.003_bb0725","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1517\/14622416.6.2.115","article-title":"Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2","volume":"6","author":"Lepper","year":"2005","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.addr.2008.11.003_bb0730","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1200\/JCO.2007.13.1128","article-title":"Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity","volume":"26","author":"Rudin","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.addr.2008.11.003_bb0735","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1182\/blood.V96.1.365","article-title":"Expression of breast cancer resistance protein in blast cells from patients with acute leukemia","volume":"96","author":"Ross","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.addr.2008.11.003_bb0740","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10555-007-9042-6","article-title":"ABCG2: determining its relevance in clinical drug resistance","volume":"26","author":"Robey","year":"2007","journal-title":"Cancer Metastasis. Rev."},{"key":"10.1016\/j.addr.2008.11.003_bb0745","doi-asserted-by":"crossref","first-page":"7896","DOI":"10.1158\/1078-0432.CCR-04-0795","article-title":"Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias","volume":"10","author":"Benderra","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2008.11.003_bb0750","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1182\/blood-2004-12-4633","article-title":"Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction","volume":"108","author":"Wilson","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.addr.2008.11.003_bb0755","first-page":"1652","article-title":"ABC transporters and inhibitors: new targets, new agents","volume":"3","author":"Leonard","year":"2002","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.addr.2008.11.003_bb0760","unstructured":"M. Garcia-Closas, S.J. Chanock, Genetic susceptibility loci for beast cancer by esgtrogen reseptor (ER) status. Clin Cancer Res (in press)."},{"key":"10.1016\/j.addr.2008.11.003_bb0765","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000108407","article-title":"MDR1 single nucleotide polymorphisms predict response to vinorelbine-based chemotherapy in patients with non-small cell lung cancer","volume":"75","author":"Pan","year":"2008","journal-title":"Respiration"},{"key":"10.1016\/j.addr.2008.11.003_bb0770","first-page":"1117","article-title":"Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer","volume":"22","author":"Kafka","year":"2003","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.addr.2008.11.003_bb0775","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1600-0609.2004.00228.x","article-title":"Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia","volume":"72","author":"Jamroziak","year":"2004","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.addr.2008.11.003_bb0780","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/jnci\/djj469","article-title":"Pharmacogenetics of ABCG2 and adverse reactions to gefitinib","volume":"98","author":"Cusatis","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.addr.2008.11.003_bb0785","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1470-2045(07)70379-0","article-title":"Part II: management of resistance to imatinib in chronic myeloid leukaemia","volume":"8","author":"Apperley","year":"2007","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.addr.2008.11.003_bb0790","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1182\/blood-2006-07-036012","article-title":"Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia","volume":"109","author":"Picard","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.addr.2008.11.003_bb0795","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1182\/blood-2006-11-056028","article-title":"Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial","volume":"109","author":"Kantarjian","year":"2007","journal-title":"Blood"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X08002524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X08002524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T01:58:28Z","timestamp":1738807108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X08002524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":159,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0169409X08002524"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2008.11.003","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}